Login / Signup

Prevalence and complication of COVID-19 in patients with ankylosing spondylitis (AS) and its relationship with TNF-a inhibitors.

Shafieh MovassaghiSeyed Ahmad Seyed AlinaghiAbdolrahman RostamianSeyed Reza NajafizadehElham Nezhadseifi
Published in: Immunity, inflammation and disease (2023)
The use of the TNF-α inhibitors in patients with AS, may be associated with reduced hospitalization and death rate in COVID-19 cases.
Keyphrases
  • ankylosing spondylitis
  • rheumatoid arthritis
  • coronavirus disease
  • sars cov
  • disease activity
  • risk factors
  • respiratory syndrome coronavirus